Table 5.
Baseline Characteristics for MB Patients Experiencing a Major Adverse Event (MAE)
| Variable | MAE | No MAE | p-value |
|---|---|---|---|
| Cases | 25 (21.2%)1 | 93 (78.8%) | - |
| Male sex | 37 (68.5%) | 44 (69.8%) | 0.877 |
| Age (years) | 61 [56, 70]2 | 64 [59, 73] | 0.280 |
| Heart Failure | 45 (81.8%) | 43 (68.3%) | 0.291 |
| Hypertension | 36 (66.7%) | 41 (65.1%) | 0.857 |
| Dialysis | 3 (5.45%) | 4 (6.4%) | 0.837 |
| Diabetes | 21 (38.2%) | 25 (39.7%) | 0.868 |
| Severe Lung Disease | 4 (7.4%) | 6 (9.5%) | 0.912 |
| Prior Cardiac Surgery | 44 (81.5%) | 45 (71.4%) | 0.204 |
| Tobacco Use | 16 (29.6%) | 30 (47.6%) | 0.047 |
| Preoperative Amiodarone Therapy | 7 (12.7%) | 11 (17.5%) | 0.476 |
| ACE-Inhibitor within 48 hours | 7 (12.7%) | 6 (9.5%) | 0.579 |
| Preoperative Diastolic Blood Pressure | 58 [43, 68] | 68 [52, 84] | 0.024 |
| Initial Postoperative White Blood Cell Count | 17.5 [13.5, 26.0] | 16.2 [13.0, 21.8] | 0.582 |
| Isolated CABG/Valve | 8 (14.6%) | 27 (42.9%) | 0.001 |
| Cross Clamp Time (minutes) | 167 [125, 234] | 147 [118, 190] | 0.021 |
| Early MB Administration | 17 (35.4%) | 31 (64.6%) | 0.044 |
1
n (%), all such values
2
median (interquartile range), all such values